Vogt Frederick G
SEC CIK 1719678 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. | GC, Interim CEO, Dir | 602.1K | $54.7K | — | 49 | 2022-06-01 | 2026-09-08 |
Most active insiders at IOVA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Kirby Daniel Gordon | Chief Commercial Off | — | — |
| 2 | Puri Raj K. | Chief Regulatory Off | — | — |
| 3 | Roche Corleen M. | CFO | — | — |
| 4 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Off | — | — |
| 5 | Vogt Frederick G | GC, Interim CEO, Dir | — | — |
| 6 | BILINSKY IGOR | COO | — | — |
Transactions 49
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-10 17:01 | 2026-09-08 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO, Dir | M - OptEx | $0.00 | +15.6K | 602.1K | +3% | $0 |
| D | 2026-09-10 17:01 | 2026-09-08 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO, Dir | F - Tax | $8.70 | -6,638 | 595.4K | -1% | -$57.8K |
| D | 2026-09-03 17:02 | 2026-09-01 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO, Dir | M - OptEx | $0.00 | +41.7K | 604.2K | +7% | $0 |
| D | 2026-09-03 17:02 | 2026-09-01 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO, Dir | F - Tax | $8.28 | -17.7K | 586.5K | -3% | -$146.6K |
| D | 2026-06-09 17:03 | 2026-06-05 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO, Dir | M - OptEx | $0.00 | +15.6K | 569.1K | +3% | $0 |
| D | 2026-06-09 17:03 | 2026-06-05 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO, Dir | F - Tax | $4.23 | -6,638 | 562.5K | -1% | -$28.1K |
| D | 2026-06-03 17:02 | 2026-06-01 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO, Dir | M - OptEx | $0.00 | +41.7K | 571.2K | +8% | $0 |
| D | 2026-06-03 17:02 | 2026-06-01 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO, Dir | F - Tax | $3.96 | -17.7K | 553.5K | -3% | -$70.1K |
| D | 2026-03-06 | 2026-03-05 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO, Dir | M - OptEx | $0.00 | +62.5K | 556.3K | +13% | $0 |
| D | 2026-03-06 | 2026-03-05 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO, Dir | F - Tax | $4.58 | -26.8K | 529.5K | -5% | -$122.5K |
| D | 2026-03-04 | 2026-03-02 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO, Dir | M - OptEx | $0.00 | +52.1K | 516.6K | +11% | $0 |
| D | 2026-03-04 | 2026-03-02 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO, Dir | F - Tax | $3.79 | -22.8K | 493.8K | -4% | -$86.4K |
| DM | 2025-12-03 | 2025-12-01+ | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO, Dir | M - OptEx | $0.00 | +52.1K | 468.9K | +12% | $0 |
| DM | 2025-12-03 | 2025-12-01+ | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO, Dir | F - Tax | $2.21 | -22.1K | 458.5K | -5% | -$48.9K |
| D | 2025-09-04 | 2025-09-02 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO, Dir | F - Tax | $2.19 | -22.1K | 434.6K | -5% | -$48.5K |
| D | 2025-09-04 | 2025-09-02 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO, Dir | M - OptEx | $0.00 | +52.1K | 456.7K | +13% | $0 |
| D | 2025-06-04 | 2025-06-02 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO, Dir | M - OptEx | $0.00 | +52.1K | 426.7K | +14% | $0 |
| D | 2025-06-04 | 2025-06-02 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO, Dir | F - Tax | $1.76 | -22.1K | 404.6K | -5% | -$38.9K |
| 2025-05-16 | 2025-05-14 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO, Dir | P - Purchase | $1.69 | +25.0K | 374.6K | +7% | +$42.2K | |
| D | 2025-03-05 | 2025-03-03 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO, Dir | F - Tax | $4.04 | -95.4K | 349.6K | -21% | -$385.5K |
| D | 2025-03-05 | 2025-03-03 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO, Dir | M - OptEx | $0.00 | +223.9K | 445.1K | +101% | $0 |
| D | 2025-01-16 | 2025-01-14 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO, Dir | F - Tax | $5.89 | -9,955 | 221.1K | -4% | -$58.6K |
| D | 2025-01-16 | 2025-01-14 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO, Dir | M - OptEx | $0.00 | +20.8K | 231.1K | +10% | $0 |
| D | 2024-12-04 | 2024-12-02 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO, Dir | M - OptEx | $0.00 | +10.4K | 214.7K | +5% | $0 |
| D | 2024-12-04 | 2024-12-02 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO, Dir | F - Tax | $9.07 | -4,426 | 210.2K | -2% | -$40.1K |
| D | 2024-10-16 | 2024-10-14 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO, Dir | M - OptEx | $0.00 | +20.8K | 213.1K | +11% | $0 |
| D | 2024-10-16 | 2024-10-14 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO, Dir | F - Tax | $9.77 | -8,851 | 204.2K | -4% | -$86.5K |
| DM | 2024-09-05 | 2024-09-03 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO, Dir | M - OptEx | $0.00 | +57.3K | 212.2K | +37% | $0 |
| DM | 2024-09-05 | 2024-09-03 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO, Dir | F - Tax | $10.85 | -24.3K | 165.3K | -13% | -$264.1K |
| D | 2024-07-17 | 2024-07-15 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO | F - Tax | $8.68 | -8,851 | 159.3K | -5% | -$76.8K |
| D | 2024-07-17 | 2024-07-15 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO | M - OptEx | $0.00 | +20.8K | 168.2K | +14% | $0 |
| D | 2024-06-05 | 2024-06-03 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO | M - OptEx | $0.00 | +10.4K | 151.8K | +7% | $0 |
| D | 2024-06-05 | 2024-06-03 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO | F - Tax | $8.37 | -4,426 | 147.3K | -3% | -$37.0K |
| D | 2024-04-17 | 2024-04-15 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO | F - Tax | $11.89 | -8,851 | 141.3K | -6% | -$105.2K |
| D | 2024-04-17 | 2024-04-15 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO | M - OptEx | $0.00 | +20.8K | 150.2K | +16% | $0 |
| D | 2024-03-06 | 2024-03-04 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO | M - OptEx | $0.00 | +41.7K | 140.8K | +42% | $0 |
| D | 2024-03-06 | 2024-03-04 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO | F - Tax | $16.96 | -11.4K | 129.4K | -8% | -$194.2K |
| D | 2024-01-18 | 2024-01-16 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO | M - OptEx | $0.00 | +20.8K | 105.7K | +25% | $0 |
| D | 2024-01-18 | 2024-01-16 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO | F - Tax | $8.37 | -6,530 | 99.1K | -6% | -$54.7K |
| D | 2023-10-18 | 2023-10-16 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO | M - OptEx | $0.00 | +20.8K | 93.7K | +29% | $0 |
| D | 2023-10-18 | 2023-10-16 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO | F - Tax | $3.57 | -8,851 | 84.8K | -9% | -$31.6K |
| D | 2023-07-17 | 2023-07-14 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO | F - Tax | $7.76 | -8,851 | 72.8K | -11% | -$68.7K |
| D | 2023-07-17 | 2023-07-14 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO | M - OptEx | $0.00 | +20.8K | 81.7K | +34% | $0 |
| D | 2023-04-18 | 2023-04-14 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO | F - Tax | $5.64 | -8,851 | 60.9K | -13% | -$49.9K |
| D | 2023-04-18 | 2023-04-14 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO | M - OptEx | $0.00 | +20.8K | 69.7K | +43% | $0 |
| D | 2023-01-19 | 2023-01-17 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO | F - Tax | $6.43 | -36.4K | 48.9K | -43% | -$234.3K |
| D | 2023-01-19 | 2023-01-17 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO | M - OptEx | $0.00 | +83.3K | 85.3K | +4,166% | $0 |
| 2022-11-28 | 2022-11-28 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO | P - Purchase | $5.98 | +1,000 | 2,000 | +100% | +$5,980 | |
| 2022-06-02 | 2022-06-01 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G | GC, Interim CEO | P - Purchase | $6.44 | +1,000 | 1,000 | New | +$6,440 |
Purchase Sale Sale after option exercise All abbreviations